Insiders Trades

★ Sign in to follow

JF

John Fitzmaurice Valliant

Executive

US·SEC (Form 4)

Fusion Pharmaceuticals Inc.

Cumul. flow

Total declarations

18

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 05 Jun 2024 for Fusion Pharmaceuticals Inc..

Insider track record

Disclosed buys

0

Disclosed sells

0

Signal history

John Fitzmaurice Valliant: trading record in brief

All filings by John Fitzmaurice Valliant on record concern Fusion Pharmaceuticals Inc. The record holds 18 filings, for trades running from 21 March 2022 to 4 June 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 5 June 2024 came the latest disclosure, a transaction in Fusion Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to John Fitzmaurice Valliant

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Fusion Pharmaceuticals Inc. (US)

Declarations18 total

●

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives4 Jun 2024Fusion Pharmaceuticals Inc.

0SEDI

318,147 sharesVoting Common SharesTSXSEDI:4324640

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives27 Apr 2022Fusion Pharmaceuticals Inc.

27,201 CAD12SEDI

4,511 shares@ CA$6.036.3% of flowVoting Common SharesTSXSEDI:3936894

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives26 Apr 2022Fusion Pharmaceuticals Inc.

13,032 CAD11SEDI

2,147 shares@ CA$6.073.0% of flowVoting Common SharesTSXSEDI:3936135

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives25 Apr 2022Fusion Pharmaceuticals Inc.

12,277 CAD11SEDI

2,036 shares@ CA$6.032.8% of flowVoting Common SharesTSXSEDI:3936134

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives21 Apr 2022Fusion Pharmaceuticals Inc.

5,541 CAD11SEDI

922 shares@ CA$6.011.3% of flowVoting Common SharesTSXSEDI:3934646

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives20 Apr 2022Fusion Pharmaceuticals Inc.

2,209 CAD11SEDI

367 shares@ CA$6.020.5% of flowVoting Common SharesTSXSEDI:3934397

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives13 Apr 2022Fusion Pharmaceuticals Inc.

76,882 CAD13SEDI

11,994 shares@ CA$6.4117.7% of flowVoting Common SharesTSXSEDI:3933279

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives11 Apr 2022Fusion Pharmaceuticals Inc.

19,162 CAD11SEDI

2,600 shares@ CA$7.374.4% of flowVoting Common SharesTSXSEDI:3932016

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives12 Apr 2022Fusion Pharmaceuticals Inc.

129,611 CAD14SEDI

18,255 shares@ CA$7.1029.8% of flowVoting Common SharesTSXSEDI:3932018

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives5 Apr 2022Fusion Pharmaceuticals Inc.

16,107 CAD11SEDI

2,100 shares@ CA$7.673.7% of flowVoting Common SharesTSXSEDI:3927704

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives6 Apr 2022Fusion Pharmaceuticals Inc.

758 CAD11SEDI

100 shares@ CA$7.580.2% of flowVoting Common SharesTSXSEDI:3927705

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives7 Apr 2022Fusion Pharmaceuticals Inc.

9,488 CAD11SEDI

1,255 shares@ CA$7.562.2% of flowVoting Common SharesTSXSEDI:3927706

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives28 Mar 2022Fusion Pharmaceuticals Inc.

72,480 CAD13SEDI

9,600 shares@ CA$7.5516.6% of flowVoting Common SharesTSXSEDI:3915875

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives25 Mar 2022Fusion Pharmaceuticals Inc.

3,710 CAD11SEDI

500 shares@ CA$7.420.8% of flowVoting Common SharesTSXSEDI:3915874

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives23 Mar 2022Fusion Pharmaceuticals Inc.

750 CAD11SEDI

100 shares@ CA$7.500.2% of flowVoting Common SharesTSXSEDI:3914459

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives24 Mar 2022Fusion Pharmaceuticals Inc.

5,222 CAD11SEDI

700 shares@ CA$7.461.2% of flowVoting Common SharesTSXSEDI:3914462

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives21 Mar 2022Fusion Pharmaceuticals Inc.

11,205 CAD11SEDI

1,500 shares@ CA$7.472.5% of flowVoting Common SharesTSXSEDI:3911553

◆

John Fitzmaurice Valliant

5 - Senior Officer of IssuerExecutives22 Mar 2022Fusion Pharmaceuticals Inc.

30,120 CAD12SEDI

4,000 shares@ CA$7.536.8% of flowVoting Common SharesTSXSEDI:3911993

18 of 18 declarations